Status:
COMPLETED
BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure Therapy
Lead Sponsor:
Emory University
Collaborating Sponsors:
Telemedicine & Advanced Technology Research Center
University of Southern California
Conditions:
Trauma
Post-Traumatic Stress Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The proposed study is designed to test the clinical efficacy of the BRAVEMIND military sexual trauma (MST) system in an initial feasibility and wait list clinical trial of 45 users. The following hyp...
Detailed Description
Pre-Treatment Assessment: Potential subjects will be asked to provide a copy of their DD214 to verify their military service record. Once a potential participant has met all screening inclusion and e...
Eligibility Criteria
Inclusion
- Participants will be 45 males and females between ages of 18 and 65
- Participants must meet DSM-V criteria for PTSD due to military sexual trauma (MST)
- Patients must be literate in English
- Patients must be medically stable
- Participants must comprehend his or her role in the study and the risks involved
Exclusion
- Patients with a history of mania, schizophrenia, or other psychoses
- Patients with active suicidal risk
- Patients with current alcohol or drug dependence
- Patients unable to wear the VR head mounted display
- Patients on psychotropic medications must have been on a stable dose for at least 2 months prior to beginning the study and must agree not to change their current medication regimen throughout the course of the study
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02246972
Start Date
May 1 2015
End Date
July 1 2017
Last Update
August 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322